Thermo Fisher Scientific, the world’s largest maker of scientific instruments, is to acquire Belgian viral vector manufacturing business Henogen for €725m (US$880.3m) in cash. A subsidiary of Groupe Novasep, Henogen provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers from two locations in Seneffe and Gosselies. Founded more than…